Product image of Glukoza Viaflo Baxter (Glucose) supplied by GNH India

Glukoza Viaflo Baxter

Active Ingredient:
Glucose
Origin:
EU

Glukoza Viaflo Baxter (Glucose)

Glukoza Viaflo Baxter is an injectable solution containing the active ingredient glucose. It is supplied as a parenteral nutrition product in an intravenous injection form, marketed in the European Union. The preparation provides a readily available source of carbohydrate energy for patients requiring intravenous glucose supplementation, such as those with hypoglycemia or needing fluid replacement.

Manufacturer / TM Owner

Baxter D.O.O.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Glukoza Viaflo Baxter is indicated for several clinical situations where intravenous glucose is required.

  • Treatment of hypoglycemia when oral glucose is not feasible.
  • Component of parenteral nutrition regimens for patients unable to receive enteral feeding.
  • Fluid replacement in patients with electrolyte or volume deficits.
  • Support during surgical procedures or critical care when rapid glucose provision is needed.
  • Adjunct therapy in metabolic disorders requiring controlled glucose administration.

Side Effects

Glukoza Viaflo Baxter may be associated with a range of adverse reactions, most of which are related to its intravenous administration.

Common

  • Local irritation or pain at the injection site.
  • Hyperglycemia when administered in excess.
  • Electrolyte imbalances, particularly sodium or potassium shifts.
  • Mild nausea or vomiting.
  • Transient headache.

Serious

  • Severe hyperglycemia leading to osmotic diuresis.
  • Allergic or anaphylactic reactions.
  • Phlebitis or thrombophlebitis at the infusion site.
  • Volume overload causing pulmonary edema.
  • Metabolic acidosis in susceptible patients.

Precautions & Warnings

When using Glukoza Viaflo Baxter, clinicians should consider several safety measures to minimize risk.

  • Assess blood glucose levels before and during infusion to avoid hyperglycemia.
  • Monitor fluid balance and cardiac status, especially in patients with heart failure.
  • Use aseptic technique to prevent infection at the infusion site.
  • Adjust dosage in patients with renal or hepatic impairment.
  • Avoid rapid infusion rates that may cause osmotic shifts.
  • Review pregnancy status; the safety profile in pregnancy is not well established.

Avoid Interactions

Glukoza Viaflo Baxter can interact with other medications or clinical conditions, requiring careful management.

Avoid

  • Concurrent administration of high-dose insulin without glucose monitoring.
  • Co-administration with other hypertonic glucose solutions, which may exacerbate hyperglycemia.
  • Use with drugs that cause fluid retention in patients at risk for overload.

Use with caution

  • Beta‑blockers, which may mask signs of hypoglycemia.
  • Corticosteroids, which can increase blood glucose levels.
  • Diuretics, which may affect electrolyte balance.
  • Medications affecting renal function, such as NSAIDs.

Frequently Asked Questions

Glukoza Viaflo Baxter is an intravenous glucose solution used to treat hypoglycemia, provide carbohydrate calories in parenteral nutrition, and assist with fluid replacement.

It is administered by intravenous infusion, typically through a peripheral or central line, under the supervision of a healthcare professional.

The product may be used in pediatric patients when prescribed, but dosing and monitoring should be individualized by a qualified clinician.

Blood glucose levels, electrolyte status, and fluid balance should be regularly monitored to avoid hyperglycemia, electrolyte disturbances, or volume overload.

The safety of Glukoza Viaflo Baxter during pregnancy has not been fully established; clinicians should weigh potential benefits against unknown risks.

Common side effects include local irritation at the infusion site, transient hyperglycemia, mild nausea, headache, and electrolyte shifts.

Serious reactions may include severe hyperglycemia, allergic or anaphylactic responses, phlebitis, volume overload leading to pulmonary edema, and metabolic acidosis.

Insulin may be required to control blood glucose, but it should be carefully coordinated with glucose infusion to prevent rapid swings in glucose levels.

Beta‑blockers can mask the typical symptoms of hypoglycemia, so glucose monitoring is especially important when both are used.

Yes, it can contribute to fluid replacement, but clinicians often combine it with other electrolyte solutions to meet specific fluid and electrolyte needs.

The ATC classification for this product is B05BA01, indicating it is a glucose solution used in parenteral nutrition.

Yes, Glukoza Viaflo Baxter is a prescription‑only medication and must be ordered by a licensed healthcare provider.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Glucose

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT